New drug breakthrough in treatment of asbestos-linked cancer
In a major breakthrough, scientists have developed a drug to treat mesothelioma, a challenging cancer associated with asbestos exposure. The new therapy, ADI-PEG20, demonstrated a remarkable fourfold increase in three-year survival rates by disrupting the tumor’s food supply. Conducted across five countries, the international trial led by Queen Mary University of London included 249 patients with pleural mesothelioma, revealing significantly improved survival compared to those on a placebo-chemotherapy regimen. This development represents a crucial advancement in addressing a cancer known for its historically low survival rates.
The groundbreaking drug, the first of its kind successfully combined with chemotherapy in two decades, provides a ray of hope for thousands globally diagnosed with mesothelioma. The study’s positive outcomes underscore the potential of ADI-PEG20 to become a standard treatment option, offering renewed optimism to patients and the medical community alike.
Read more here
To join the debates, discover more industry insights, and stay up to date with the latest Lab Innovation news make sure you register your interest for Lab Innovations 2024.
About Lab Innovations
Lab Innovations has fast become the UK’s must-attend event for the entire laboratory industry. Supported by some of the UK’s top science institutions, it is a key event for powering the business of science.
The show floor is bursting with innovations from more than 160 leading scientific suppliers and manufacturers showcasing the latest laboratory developments and equipment. Exhibitors present the most cutting-edge technology applicable to a plethora of industries including life sciences, pharmaceuticals, academia, healthcare, chemical, food & drink, cleanroom and more.
About Easyfairs
In 2018 Easyfairs was named Belgium’s “Entrepreneur of the Year®” and a “Great Place to Work”. For the fourth year running, Deloitte conferred “Best Managed Company” status on Easyfairs in 2022.
Visit the future with Easyfairs and find out more on www.easyfairs.com.
For further information, please contact:
Aleiya Lonsdale Patrick Ball & Chloe Luckham
Lab Innovations Stone Junction Ltd
aleiya.londsdale@easyfairs.com Patrick@stonejunction.co.uk & chloe@stonejunction.co.uk
